Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Combined Effect of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on the Progressing of Kidney Disease in Patients With Type 2 Diabetes Compared to Single Administration of Each of These Two Drugs



Sanadgol H1 ; Tamadon MR2 ; Dashipour A3 ; Ghazanfari H4 ; Khodadadi S5 ; Nasri H6
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Nephrology, School of Medicine AND Nephrology Research Center, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Nephrology, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran
  3. 3. Department of Nutrition, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran
  4. 4. Department of Internal Medicine, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran
  5. 5. Department of Biology, Falavarjan Branch, Islamic Azad Uiniversity, Falavarjan, Iran
  6. 6. Department of Internal Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Journal of Isfahan Medical School Published:2016

Abstract

Background: Inhibition of the renin-angiotensin system in patients with diabetic nephropathy can reduce proteinuria and slow down renal impairment. In this study, we aimed to evaluate the preventive effects of prescribing both angiotensin converting enzyme inhibitors (ACEI) and angiotensin receptor inhibitors (ARBs) for renal disease progression compared with administrating each of these two medications alone in patients with type 2 diabetes. Methods: 90 patients with diabetic nephropathy were randomized into three groups: receiving captopril, losartan, and losartan in combination with captopril. Proteinuria was measured before, 2, 6 and 12 months after intervention, and creatinine clearance was measured before and after intervention. Repeated measures ANOVA, Fisher’s least significant difference (Fisher’s LSD), and t-test were used for data analysis by SPSS software. Findings: Proteinuria was improved in all groups who received medication (P < 0.001). This reduction in the group who received losartan in combined to captopril was more than other groups (P = 0.026). Creatinine clearance was not significantly different between all groups. Conclusion: Administration of ACEI or ARBs reduced proteinuria in patients suffering from diabetic nephropathy (due to type 2 diabetes) but prescribing both drugs had a significantly better outcome. However, creatinine clearance was not significantly improved in any of the groups. © 2016, Isfahan University of Medical Sciences(IUMS). All rights reserved.
Related Docs
1. Cancer Phytotherapy: Recent Views on the Role of Antioxidant and Angiogenesis Activities, Journal of Evidence-Based Complementary and Alternative Medicine (2017)
2. Urinary N-Acetyl-Β-D-Glucosaminidase (Nag) Activity in the Early Detection of Diabetic Nephropathy, International Journal of Diabetes in Developing Countries (2015)
3. Medicinal Plants for the Treatment of Acne Vulgaris: A Review of Recent Evidences, Jundishapur Journal of Microbiology (2015)
4. Antioxidant Activity and Properties of Walnut Brown Seed Coat Extract, Journal of Global Pharma Technology (2016)
Experts (# of related papers)
Parisa Sadighara (1)
Bagher Larijani (1)